BEACON - ABC in Recurrent Platinum Resistant HGSOC

Clinical trial NCT03363867 · UNKNOWN

Trial details

NCT number: NCT03363867
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2018-07-10
Primary completion: 2024-02-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.